nodes	percent_of_prediction	percent_of_DWPC	metapath
Halofantrine—CYP2C8—Bortezomib—hematologic cancer	0.0307	0.044	CbGbCtD
Halofantrine—CYP3A5—Daunorubicin—hematologic cancer	0.0306	0.0438	CbGbCtD
Halofantrine—CYP2D6—Lomustine—hematologic cancer	0.0297	0.0426	CbGbCtD
Halofantrine—CYP3A5—Thalidomide—hematologic cancer	0.0279	0.0399	CbGbCtD
Halofantrine—CYP3A5—Teniposide—hematologic cancer	0.0266	0.038	CbGbCtD
Halofantrine—CYP2D6—Idarubicin—hematologic cancer	0.0265	0.0379	CbGbCtD
Halofantrine—CYP3A5—Ifosfamide—hematologic cancer	0.0245	0.0351	CbGbCtD
Halofantrine—CYP2C8—Ifosfamide—hematologic cancer	0.0236	0.0338	CbGbCtD
Halofantrine—CYP3A5—Imatinib—hematologic cancer	0.0234	0.0335	CbGbCtD
Halofantrine—CYP2D6—Hydroxyurea—hematologic cancer	0.0225	0.0323	CbGbCtD
Halofantrine—CYP2C8—Nilotinib—hematologic cancer	0.0205	0.0293	CbGbCtD
Halofantrine—CYP3A4—Bexarotene—hematologic cancer	0.0203	0.0291	CbGbCtD
Halofantrine—CYP2D6—Bortezomib—hematologic cancer	0.0196	0.0281	CbGbCtD
Halofantrine—CYP3A4—Busulfan—hematologic cancer	0.0189	0.0271	CbGbCtD
Halofantrine—CYP3A4—Lomustine—hematologic cancer	0.0189	0.0271	CbGbCtD
Halofantrine—CYP3A5—Dasatinib—hematologic cancer	0.0188	0.0269	CbGbCtD
Halofantrine—CYP3A4—Thiotepa—hematologic cancer	0.0169	0.0241	CbGbCtD
Halofantrine—CYP3A5—Irinotecan—hematologic cancer	0.0146	0.0209	CbGbCtD
Halofantrine—CYP2D6—Imatinib—hematologic cancer	0.0144	0.0206	CbGbCtD
Halofantrine—CYP3A4—Methoxsalen—hematologic cancer	0.0131	0.0188	CbGbCtD
Halofantrine—CYP2D6—Nilotinib—hematologic cancer	0.0131	0.0187	CbGbCtD
Halofantrine—CYP2D6—Vinorelbine—hematologic cancer	0.0129	0.0185	CbGbCtD
Halofantrine—CYP3A5—Vincristine—hematologic cancer	0.0128	0.0183	CbGbCtD
Halofantrine—CYP3A4—Bortezomib—hematologic cancer	0.0125	0.0178	CbGbCtD
Halofantrine—CYP3A4—Daunorubicin—hematologic cancer	0.0119	0.0171	CbGbCtD
Halofantrine—CYP3A5—Etoposide—hematologic cancer	0.0117	0.0168	CbGbCtD
Halofantrine—CYP2C8—Etoposide—hematologic cancer	0.0113	0.0161	CbGbCtD
Halofantrine—CYP3A4—Cytarabine—hematologic cancer	0.0105	0.0151	CbGbCtD
Halofantrine—CYP3A4—Teniposide—hematologic cancer	0.0104	0.0148	CbGbCtD
Halofantrine—CYP3A5—Dexamethasone—hematologic cancer	0.00964	0.0138	CbGbCtD
Halofantrine—CYP3A4—Ifosfamide—hematologic cancer	0.00956	0.0137	CbGbCtD
Halofantrine—CYP2C8—Dexamethasone—hematologic cancer	0.00927	0.0133	CbGbCtD
Halofantrine—CYP3A4—Imatinib—hematologic cancer	0.00914	0.0131	CbGbCtD
Halofantrine—CYP3A4—Ruxolitinib—hematologic cancer	0.0086	0.0123	CbGbCtD
Halofantrine—CYP3A4—Nilotinib—hematologic cancer	0.0083	0.0119	CbGbCtD
Halofantrine—CYP3A4—Vinorelbine—hematologic cancer	0.00823	0.0118	CbGbCtD
Halofantrine—CYP2D6—Vinblastine—hematologic cancer	0.00798	0.0114	CbGbCtD
Halofantrine—CYP3A4—Triamcinolone—hematologic cancer	0.00753	0.0108	CbGbCtD
Halofantrine—CYP3A4—Dasatinib—hematologic cancer	0.00734	0.0105	CbGbCtD
Halofantrine—CYP3A4—Mitoxantrone—hematologic cancer	0.00725	0.0104	CbGbCtD
Halofantrine—CYP3A4—Betamethasone—hematologic cancer	0.00646	0.00925	CbGbCtD
Halofantrine—CYP3A4—Prednisolone—hematologic cancer	0.00637	0.00912	CbGbCtD
Halofantrine—CYP3A4—Prednisone—hematologic cancer	0.00602	0.00862	CbGbCtD
Halofantrine—CYP2D6—Dexamethasone—hematologic cancer	0.00591	0.00846	CbGbCtD
Halofantrine—CYP3A4—Irinotecan—hematologic cancer	0.00571	0.00817	CbGbCtD
Halofantrine—CYP3A4—Vinblastine—hematologic cancer	0.00507	0.00726	CbGbCtD
Halofantrine—CYP3A4—Vincristine—hematologic cancer	0.00499	0.00714	CbGbCtD
Halofantrine—CYP2D6—Doxorubicin—hematologic cancer	0.0049	0.00702	CbGbCtD
Halofantrine—CYP3A4—Etoposide—hematologic cancer	0.00457	0.00654	CbGbCtD
Halofantrine—CYP3A4—Dexamethasone—hematologic cancer	0.00376	0.00538	CbGbCtD
Halofantrine—CYP3A4—Doxorubicin—hematologic cancer	0.00312	0.00446	CbGbCtD
Halofantrine—Anaphylactic shock—Dexamethasone—hematologic cancer	8.75e-05	0.000332	CcSEcCtD
Halofantrine—Diarrhoea—Mitoxantrone—hematologic cancer	8.74e-05	0.000332	CcSEcCtD
Halofantrine—Diarrhoea—Irinotecan—hematologic cancer	8.74e-05	0.000332	CcSEcCtD
Halofantrine—Vomiting—Carmustine—hematologic cancer	8.74e-05	0.000332	CcSEcCtD
Halofantrine—Gastrointestinal pain—Etoposide—hematologic cancer	8.69e-05	0.00033	CcSEcCtD
Halofantrine—Dizziness—Vincristine—hematologic cancer	8.68e-05	0.000329	CcSEcCtD
Halofantrine—Rash—Carmustine—hematologic cancer	8.67e-05	0.000329	CcSEcCtD
Halofantrine—Ill-defined disorder—Prednisone—hematologic cancer	8.66e-05	0.000329	CcSEcCtD
Halofantrine—Dermatitis—Carmustine—hematologic cancer	8.66e-05	0.000329	CcSEcCtD
Halofantrine—Vomiting—Alitretinoin—hematologic cancer	8.66e-05	0.000329	CcSEcCtD
Halofantrine—Paraesthesia—Triamcinolone—hematologic cancer	8.66e-05	0.000329	CcSEcCtD
Halofantrine—Feeling abnormal—Prednisolone—hematologic cancer	8.64e-05	0.000328	CcSEcCtD
Halofantrine—Visual impairment—Methotrexate—hematologic cancer	8.64e-05	0.000328	CcSEcCtD
Halofantrine—Headache—Carmustine—hematologic cancer	8.61e-05	0.000327	CcSEcCtD
Halofantrine—Rash—Alitretinoin—hematologic cancer	8.59e-05	0.000326	CcSEcCtD
Halofantrine—Dermatitis—Alitretinoin—hematologic cancer	8.58e-05	0.000326	CcSEcCtD
Halofantrine—Vomiting—Ifosfamide—hematologic cancer	8.56e-05	0.000325	CcSEcCtD
Halofantrine—Headache—Alitretinoin—hematologic cancer	8.53e-05	0.000324	CcSEcCtD
Halofantrine—Diarrhoea—Gemcitabine—hematologic cancer	8.52e-05	0.000323	CcSEcCtD
Halofantrine—Nausea—Thalidomide—hematologic cancer	8.5e-05	0.000323	CcSEcCtD
Halofantrine—Dyspepsia—Triamcinolone—hematologic cancer	8.49e-05	0.000322	CcSEcCtD
Halofantrine—Rash—Ifosfamide—hematologic cancer	8.49e-05	0.000322	CcSEcCtD
Halofantrine—Dermatitis—Ifosfamide—hematologic cancer	8.48e-05	0.000322	CcSEcCtD
Halofantrine—Dizziness—Irinotecan—hematologic cancer	8.45e-05	0.000321	CcSEcCtD
Halofantrine—Urticaria—Etoposide—hematologic cancer	8.44e-05	0.000321	CcSEcCtD
Halofantrine—Stomatitis—Doxorubicin—hematologic cancer	8.43e-05	0.00032	CcSEcCtD
Halofantrine—Malaise—Prednisone—hematologic cancer	8.42e-05	0.00032	CcSEcCtD
Halofantrine—Abdominal pain—Etoposide—hematologic cancer	8.4e-05	0.000319	CcSEcCtD
Halofantrine—Tinnitus—Methotrexate—hematologic cancer	8.36e-05	0.000317	CcSEcCtD
Halofantrine—Vomiting—Vincristine—hematologic cancer	8.34e-05	0.000317	CcSEcCtD
Halofantrine—Anorexia—Dexamethasone—hematologic cancer	8.34e-05	0.000317	CcSEcCtD
Halofantrine—Anorexia—Betamethasone—hematologic cancer	8.34e-05	0.000317	CcSEcCtD
Halofantrine—Urticaria—Prednisolone—hematologic cancer	8.33e-05	0.000316	CcSEcCtD
Halofantrine—Asthenia—Cisplatin—hematologic cancer	8.32e-05	0.000316	CcSEcCtD
Halofantrine—Fatigue—Triamcinolone—hematologic cancer	8.31e-05	0.000316	CcSEcCtD
Halofantrine—Rash—Vincristine—hematologic cancer	8.27e-05	0.000314	CcSEcCtD
Halofantrine—Dermatitis—Vincristine—hematologic cancer	8.27e-05	0.000314	CcSEcCtD
Halofantrine—Headache—Vincristine—hematologic cancer	8.22e-05	0.000312	CcSEcCtD
Halofantrine—Nausea—Carmustine—hematologic cancer	8.16e-05	0.00031	CcSEcCtD
Halofantrine—Vomiting—Irinotecan—hematologic cancer	8.12e-05	0.000309	CcSEcCtD
Halofantrine—Vomiting—Mitoxantrone—hematologic cancer	8.12e-05	0.000309	CcSEcCtD
Halofantrine—Nausea—Alitretinoin—hematologic cancer	8.09e-05	0.000307	CcSEcCtD
Halofantrine—Convulsion—Prednisone—hematologic cancer	8.09e-05	0.000307	CcSEcCtD
Halofantrine—Visual impairment—Epirubicin—hematologic cancer	8.08e-05	0.000307	CcSEcCtD
Halofantrine—Rash—Mitoxantrone—hematologic cancer	8.06e-05	0.000306	CcSEcCtD
Halofantrine—Rash—Irinotecan—hematologic cancer	8.06e-05	0.000306	CcSEcCtD
Halofantrine—Dermatitis—Irinotecan—hematologic cancer	8.05e-05	0.000306	CcSEcCtD
Halofantrine—Dermatitis—Mitoxantrone—hematologic cancer	8.05e-05	0.000306	CcSEcCtD
Halofantrine—Chills—Methotrexate—hematologic cancer	8.04e-05	0.000305	CcSEcCtD
Halofantrine—Headache—Irinotecan—hematologic cancer	8.01e-05	0.000304	CcSEcCtD
Halofantrine—Headache—Mitoxantrone—hematologic cancer	8.01e-05	0.000304	CcSEcCtD
Halofantrine—Nausea—Ifosfamide—hematologic cancer	7.99e-05	0.000304	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	7.97e-05	0.000303	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	7.97e-05	0.000303	CcSEcCtD
Halofantrine—Arthralgia—Prednisone—hematologic cancer	7.95e-05	0.000302	CcSEcCtD
Halofantrine—Myalgia—Prednisone—hematologic cancer	7.95e-05	0.000302	CcSEcCtD
Halofantrine—Feeling abnormal—Triamcinolone—hematologic cancer	7.94e-05	0.000302	CcSEcCtD
Halofantrine—Diarrhoea—Cisplatin—hematologic cancer	7.94e-05	0.000301	CcSEcCtD
Halofantrine—Vomiting—Gemcitabine—hematologic cancer	7.91e-05	0.000301	CcSEcCtD
Halofantrine—Paraesthesia—Dexamethasone—hematologic cancer	7.85e-05	0.000298	CcSEcCtD
Halofantrine—Paraesthesia—Betamethasone—hematologic cancer	7.85e-05	0.000298	CcSEcCtD
Halofantrine—Discomfort—Prednisone—hematologic cancer	7.85e-05	0.000298	CcSEcCtD
Halofantrine—Rash—Gemcitabine—hematologic cancer	7.85e-05	0.000298	CcSEcCtD
Halofantrine—Dermatitis—Gemcitabine—hematologic cancer	7.84e-05	0.000298	CcSEcCtD
Halofantrine—Tinnitus—Epirubicin—hematologic cancer	7.82e-05	0.000297	CcSEcCtD
Halofantrine—Headache—Gemcitabine—hematologic cancer	7.8e-05	0.000296	CcSEcCtD
Halofantrine—Nausea—Vincristine—hematologic cancer	7.79e-05	0.000296	CcSEcCtD
Halofantrine—Dyspepsia—Dexamethasone—hematologic cancer	7.7e-05	0.000292	CcSEcCtD
Halofantrine—Dyspepsia—Betamethasone—hematologic cancer	7.7e-05	0.000292	CcSEcCtD
Halofantrine—Urticaria—Triamcinolone—hematologic cancer	7.66e-05	0.000291	CcSEcCtD
Halofantrine—Asthenia—Etoposide—hematologic cancer	7.63e-05	0.00029	CcSEcCtD
Halofantrine—Anaphylactic shock—Prednisone—hematologic cancer	7.62e-05	0.000289	CcSEcCtD
Halofantrine—Decreased appetite—Dexamethasone—hematologic cancer	7.6e-05	0.000289	CcSEcCtD
Halofantrine—Decreased appetite—Betamethasone—hematologic cancer	7.6e-05	0.000289	CcSEcCtD
Halofantrine—Nausea—Mitoxantrone—hematologic cancer	7.59e-05	0.000288	CcSEcCtD
Halofantrine—Nausea—Irinotecan—hematologic cancer	7.59e-05	0.000288	CcSEcCtD
Halofantrine—Back pain—Methotrexate—hematologic cancer	7.55e-05	0.000287	CcSEcCtD
Halofantrine—Fatigue—Betamethasone—hematologic cancer	7.54e-05	0.000286	CcSEcCtD
Halofantrine—Fatigue—Dexamethasone—hematologic cancer	7.54e-05	0.000286	CcSEcCtD
Halofantrine—Chills—Epirubicin—hematologic cancer	7.52e-05	0.000286	CcSEcCtD
Halofantrine—Pruritus—Etoposide—hematologic cancer	7.52e-05	0.000286	CcSEcCtD
Halofantrine—Arrhythmia—Epirubicin—hematologic cancer	7.49e-05	0.000284	CcSEcCtD
Halofantrine—Visual impairment—Doxorubicin—hematologic cancer	7.48e-05	0.000284	CcSEcCtD
Halofantrine—Nausea—Gemcitabine—hematologic cancer	7.39e-05	0.000281	CcSEcCtD
Halofantrine—Vomiting—Cisplatin—hematologic cancer	7.38e-05	0.00028	CcSEcCtD
Halofantrine—Rash—Cisplatin—hematologic cancer	7.32e-05	0.000278	CcSEcCtD
Halofantrine—Dermatitis—Cisplatin—hematologic cancer	7.31e-05	0.000278	CcSEcCtD
Halofantrine—Diarrhoea—Etoposide—hematologic cancer	7.27e-05	0.000276	CcSEcCtD
Halofantrine—Anorexia—Prednisone—hematologic cancer	7.26e-05	0.000276	CcSEcCtD
Halofantrine—Ill-defined disorder—Methotrexate—hematologic cancer	7.24e-05	0.000275	CcSEcCtD
Halofantrine—Tinnitus—Doxorubicin—hematologic cancer	7.23e-05	0.000275	CcSEcCtD
Halofantrine—Feeling abnormal—Dexamethasone—hematologic cancer	7.21e-05	0.000274	CcSEcCtD
Halofantrine—Feeling abnormal—Betamethasone—hematologic cancer	7.21e-05	0.000274	CcSEcCtD
Halofantrine—Gastrointestinal pain—Dexamethasone—hematologic cancer	7.15e-05	0.000272	CcSEcCtD
Halofantrine—Gastrointestinal pain—Betamethasone—hematologic cancer	7.15e-05	0.000272	CcSEcCtD
Halofantrine—Back pain—Epirubicin—hematologic cancer	7.06e-05	0.000268	CcSEcCtD
Halofantrine—Malaise—Methotrexate—hematologic cancer	7.03e-05	0.000267	CcSEcCtD
Halofantrine—Dizziness—Etoposide—hematologic cancer	7.03e-05	0.000267	CcSEcCtD
Halofantrine—Chills—Doxorubicin—hematologic cancer	6.96e-05	0.000264	CcSEcCtD
Halofantrine—Urticaria—Betamethasone—hematologic cancer	6.95e-05	0.000264	CcSEcCtD
Halofantrine—Urticaria—Dexamethasone—hematologic cancer	6.95e-05	0.000264	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Prednisone—hematologic cancer	6.94e-05	0.000264	CcSEcCtD
Halofantrine—Dizziness—Prednisolone—hematologic cancer	6.93e-05	0.000263	CcSEcCtD
Halofantrine—Arrhythmia—Doxorubicin—hematologic cancer	6.93e-05	0.000263	CcSEcCtD
Halofantrine—Asthenia—Triamcinolone—hematologic cancer	6.92e-05	0.000263	CcSEcCtD
Halofantrine—Abdominal pain—Betamethasone—hematologic cancer	6.91e-05	0.000263	CcSEcCtD
Halofantrine—Abdominal pain—Dexamethasone—hematologic cancer	6.91e-05	0.000263	CcSEcCtD
Halofantrine—Nausea—Cisplatin—hematologic cancer	6.89e-05	0.000262	CcSEcCtD
Halofantrine—Paraesthesia—Prednisone—hematologic cancer	6.84e-05	0.00026	CcSEcCtD
Halofantrine—Pruritus—Triamcinolone—hematologic cancer	6.82e-05	0.000259	CcSEcCtD
Halofantrine—Cough—Methotrexate—hematologic cancer	6.81e-05	0.000258	CcSEcCtD
Halofantrine—Ill-defined disorder—Epirubicin—hematologic cancer	6.77e-05	0.000257	CcSEcCtD
Halofantrine—Convulsion—Methotrexate—hematologic cancer	6.76e-05	0.000257	CcSEcCtD
Halofantrine—Vomiting—Etoposide—hematologic cancer	6.76e-05	0.000257	CcSEcCtD
Halofantrine—Dyspepsia—Prednisone—hematologic cancer	6.71e-05	0.000255	CcSEcCtD
Halofantrine—Rash—Etoposide—hematologic cancer	6.7e-05	0.000254	CcSEcCtD
Halofantrine—Dermatitis—Etoposide—hematologic cancer	6.7e-05	0.000254	CcSEcCtD
Halofantrine—Headache—Etoposide—hematologic cancer	6.66e-05	0.000253	CcSEcCtD
Halofantrine—Chest pain—Methotrexate—hematologic cancer	6.64e-05	0.000252	CcSEcCtD
Halofantrine—Myalgia—Methotrexate—hematologic cancer	6.64e-05	0.000252	CcSEcCtD
Halofantrine—Arthralgia—Methotrexate—hematologic cancer	6.64e-05	0.000252	CcSEcCtD
Halofantrine—Decreased appetite—Prednisone—hematologic cancer	6.62e-05	0.000251	CcSEcCtD
Halofantrine—Rash—Prednisolone—hematologic cancer	6.61e-05	0.000251	CcSEcCtD
Halofantrine—Dermatitis—Prednisolone—hematologic cancer	6.6e-05	0.000251	CcSEcCtD
Halofantrine—Malaise—Epirubicin—hematologic cancer	6.58e-05	0.00025	CcSEcCtD
Halofantrine—Fatigue—Prednisone—hematologic cancer	6.57e-05	0.000249	CcSEcCtD
Halofantrine—Headache—Prednisolone—hematologic cancer	6.57e-05	0.000249	CcSEcCtD
Halofantrine—Discomfort—Methotrexate—hematologic cancer	6.56e-05	0.000249	CcSEcCtD
Halofantrine—Back pain—Doxorubicin—hematologic cancer	6.53e-05	0.000248	CcSEcCtD
Halofantrine—Constipation—Prednisone—hematologic cancer	6.51e-05	0.000247	CcSEcCtD
Halofantrine—Palpitations—Epirubicin—hematologic cancer	6.45e-05	0.000245	CcSEcCtD
Halofantrine—Confusional state—Methotrexate—hematologic cancer	6.42e-05	0.000244	CcSEcCtD
Halofantrine—Dizziness—Triamcinolone—hematologic cancer	6.38e-05	0.000242	CcSEcCtD
Halofantrine—Cough—Epirubicin—hematologic cancer	6.37e-05	0.000242	CcSEcCtD
Halofantrine—Anaphylactic shock—Methotrexate—hematologic cancer	6.37e-05	0.000242	CcSEcCtD
Halofantrine—Convulsion—Epirubicin—hematologic cancer	6.33e-05	0.00024	CcSEcCtD
Halofantrine—Nausea—Etoposide—hematologic cancer	6.31e-05	0.00024	CcSEcCtD
Halofantrine—Feeling abnormal—Prednisone—hematologic cancer	6.28e-05	0.000238	CcSEcCtD
Halofantrine—Asthenia—Dexamethasone—hematologic cancer	6.28e-05	0.000238	CcSEcCtD
Halofantrine—Asthenia—Betamethasone—hematologic cancer	6.28e-05	0.000238	CcSEcCtD
Halofantrine—Ill-defined disorder—Doxorubicin—hematologic cancer	6.27e-05	0.000238	CcSEcCtD
Halofantrine—Gastrointestinal pain—Prednisone—hematologic cancer	6.23e-05	0.000237	CcSEcCtD
Halofantrine—Nausea—Prednisolone—hematologic cancer	6.23e-05	0.000236	CcSEcCtD
Halofantrine—Myalgia—Epirubicin—hematologic cancer	6.22e-05	0.000236	CcSEcCtD
Halofantrine—Arthralgia—Epirubicin—hematologic cancer	6.22e-05	0.000236	CcSEcCtD
Halofantrine—Chest pain—Epirubicin—hematologic cancer	6.22e-05	0.000236	CcSEcCtD
Halofantrine—Pruritus—Betamethasone—hematologic cancer	6.19e-05	0.000235	CcSEcCtD
Halofantrine—Pruritus—Dexamethasone—hematologic cancer	6.19e-05	0.000235	CcSEcCtD
Halofantrine—Discomfort—Epirubicin—hematologic cancer	6.14e-05	0.000233	CcSEcCtD
Halofantrine—Vomiting—Triamcinolone—hematologic cancer	6.13e-05	0.000233	CcSEcCtD
Halofantrine—Malaise—Doxorubicin—hematologic cancer	6.09e-05	0.000231	CcSEcCtD
Halofantrine—Rash—Triamcinolone—hematologic cancer	6.08e-05	0.000231	CcSEcCtD
Halofantrine—Dermatitis—Triamcinolone—hematologic cancer	6.07e-05	0.000231	CcSEcCtD
Halofantrine—Anorexia—Methotrexate—hematologic cancer	6.07e-05	0.00023	CcSEcCtD
Halofantrine—Urticaria—Prednisone—hematologic cancer	6.05e-05	0.00023	CcSEcCtD
Halofantrine—Headache—Triamcinolone—hematologic cancer	6.04e-05	0.000229	CcSEcCtD
Halofantrine—Abdominal pain—Prednisone—hematologic cancer	6.02e-05	0.000229	CcSEcCtD
Halofantrine—Confusional state—Epirubicin—hematologic cancer	6.01e-05	0.000228	CcSEcCtD
Halofantrine—Diarrhoea—Dexamethasone—hematologic cancer	5.99e-05	0.000227	CcSEcCtD
Halofantrine—Diarrhoea—Betamethasone—hematologic cancer	5.99e-05	0.000227	CcSEcCtD
Halofantrine—Palpitations—Doxorubicin—hematologic cancer	5.97e-05	0.000227	CcSEcCtD
Halofantrine—Anaphylactic shock—Epirubicin—hematologic cancer	5.96e-05	0.000226	CcSEcCtD
Halofantrine—Cough—Doxorubicin—hematologic cancer	5.89e-05	0.000224	CcSEcCtD
Halofantrine—Convulsion—Doxorubicin—hematologic cancer	5.85e-05	0.000222	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	5.8e-05	0.00022	CcSEcCtD
Halofantrine—Dizziness—Betamethasone—hematologic cancer	5.78e-05	0.00022	CcSEcCtD
Halofantrine—Dizziness—Dexamethasone—hematologic cancer	5.78e-05	0.00022	CcSEcCtD
Halofantrine—Myalgia—Doxorubicin—hematologic cancer	5.75e-05	0.000218	CcSEcCtD
Halofantrine—Chest pain—Doxorubicin—hematologic cancer	5.75e-05	0.000218	CcSEcCtD
Halofantrine—Arthralgia—Doxorubicin—hematologic cancer	5.75e-05	0.000218	CcSEcCtD
Halofantrine—Nausea—Triamcinolone—hematologic cancer	5.73e-05	0.000217	CcSEcCtD
Halofantrine—Paraesthesia—Methotrexate—hematologic cancer	5.72e-05	0.000217	CcSEcCtD
Halofantrine—Discomfort—Doxorubicin—hematologic cancer	5.68e-05	0.000216	CcSEcCtD
Halofantrine—Anorexia—Epirubicin—hematologic cancer	5.68e-05	0.000216	CcSEcCtD
Halofantrine—Dyspepsia—Methotrexate—hematologic cancer	5.6e-05	0.000213	CcSEcCtD
Halofantrine—Vomiting—Dexamethasone—hematologic cancer	5.56e-05	0.000211	CcSEcCtD
Halofantrine—Vomiting—Betamethasone—hematologic cancer	5.56e-05	0.000211	CcSEcCtD
Halofantrine—Confusional state—Doxorubicin—hematologic cancer	5.56e-05	0.000211	CcSEcCtD
Halofantrine—Decreased appetite—Methotrexate—hematologic cancer	5.53e-05	0.00021	CcSEcCtD
Halofantrine—Rash—Betamethasone—hematologic cancer	5.52e-05	0.000209	CcSEcCtD
Halofantrine—Rash—Dexamethasone—hematologic cancer	5.52e-05	0.000209	CcSEcCtD
Halofantrine—Anaphylactic shock—Doxorubicin—hematologic cancer	5.51e-05	0.000209	CcSEcCtD
Halofantrine—Dermatitis—Betamethasone—hematologic cancer	5.51e-05	0.000209	CcSEcCtD
Halofantrine—Dermatitis—Dexamethasone—hematologic cancer	5.51e-05	0.000209	CcSEcCtD
Halofantrine—Fatigue—Methotrexate—hematologic cancer	5.49e-05	0.000208	CcSEcCtD
Halofantrine—Headache—Betamethasone—hematologic cancer	5.48e-05	0.000208	CcSEcCtD
Halofantrine—Headache—Dexamethasone—hematologic cancer	5.48e-05	0.000208	CcSEcCtD
Halofantrine—Asthenia—Prednisone—hematologic cancer	5.47e-05	0.000208	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	5.43e-05	0.000206	CcSEcCtD
Halofantrine—Pruritus—Prednisone—hematologic cancer	5.39e-05	0.000205	CcSEcCtD
Halofantrine—Paraesthesia—Epirubicin—hematologic cancer	5.35e-05	0.000203	CcSEcCtD
Halofantrine—Anorexia—Doxorubicin—hematologic cancer	5.25e-05	0.0002	CcSEcCtD
Halofantrine—Feeling abnormal—Methotrexate—hematologic cancer	5.25e-05	0.000199	CcSEcCtD
Halofantrine—Dyspepsia—Epirubicin—hematologic cancer	5.24e-05	0.000199	CcSEcCtD
Halofantrine—Diarrhoea—Prednisone—hematologic cancer	5.21e-05	0.000198	CcSEcCtD
Halofantrine—Gastrointestinal pain—Methotrexate—hematologic cancer	5.21e-05	0.000198	CcSEcCtD
Halofantrine—Nausea—Dexamethasone—hematologic cancer	5.2e-05	0.000197	CcSEcCtD
Halofantrine—Nausea—Betamethasone—hematologic cancer	5.2e-05	0.000197	CcSEcCtD
Halofantrine—Decreased appetite—Epirubicin—hematologic cancer	5.18e-05	0.000197	CcSEcCtD
Halofantrine—Fatigue—Epirubicin—hematologic cancer	5.14e-05	0.000195	CcSEcCtD
Halofantrine—Constipation—Epirubicin—hematologic cancer	5.09e-05	0.000193	CcSEcCtD
Halofantrine—Urticaria—Methotrexate—hematologic cancer	5.06e-05	0.000192	CcSEcCtD
Halofantrine—Dizziness—Prednisone—hematologic cancer	5.04e-05	0.000191	CcSEcCtD
Halofantrine—Abdominal pain—Methotrexate—hematologic cancer	5.03e-05	0.000191	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	5.02e-05	0.000191	CcSEcCtD
Halofantrine—Paraesthesia—Doxorubicin—hematologic cancer	4.95e-05	0.000188	CcSEcCtD
Halofantrine—Feeling abnormal—Epirubicin—hematologic cancer	4.91e-05	0.000186	CcSEcCtD
Halofantrine—Gastrointestinal pain—Epirubicin—hematologic cancer	4.87e-05	0.000185	CcSEcCtD
Halofantrine—Dyspepsia—Doxorubicin—hematologic cancer	4.85e-05	0.000184	CcSEcCtD
Halofantrine—Vomiting—Prednisone—hematologic cancer	4.84e-05	0.000184	CcSEcCtD
Halofantrine—Rash—Prednisone—hematologic cancer	4.8e-05	0.000182	CcSEcCtD
Halofantrine—Dermatitis—Prednisone—hematologic cancer	4.8e-05	0.000182	CcSEcCtD
Halofantrine—Decreased appetite—Doxorubicin—hematologic cancer	4.79e-05	0.000182	CcSEcCtD
Halofantrine—Headache—Prednisone—hematologic cancer	4.77e-05	0.000181	CcSEcCtD
Halofantrine—Fatigue—Doxorubicin—hematologic cancer	4.75e-05	0.00018	CcSEcCtD
Halofantrine—Urticaria—Epirubicin—hematologic cancer	4.73e-05	0.00018	CcSEcCtD
Halofantrine—Constipation—Doxorubicin—hematologic cancer	4.71e-05	0.000179	CcSEcCtD
Halofantrine—Abdominal pain—Epirubicin—hematologic cancer	4.71e-05	0.000179	CcSEcCtD
Halofantrine—Asthenia—Methotrexate—hematologic cancer	4.57e-05	0.000173	CcSEcCtD
Halofantrine—Feeling abnormal—Doxorubicin—hematologic cancer	4.54e-05	0.000173	CcSEcCtD
Halofantrine—Nausea—Prednisone—hematologic cancer	4.52e-05	0.000172	CcSEcCtD
Halofantrine—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.51e-05	0.000171	CcSEcCtD
Halofantrine—Pruritus—Methotrexate—hematologic cancer	4.5e-05	0.000171	CcSEcCtD
Halofantrine—Urticaria—Doxorubicin—hematologic cancer	4.38e-05	0.000166	CcSEcCtD
Halofantrine—Abdominal pain—Doxorubicin—hematologic cancer	4.36e-05	0.000165	CcSEcCtD
Halofantrine—Diarrhoea—Methotrexate—hematologic cancer	4.36e-05	0.000165	CcSEcCtD
Halofantrine—Asthenia—Epirubicin—hematologic cancer	4.27e-05	0.000162	CcSEcCtD
Halofantrine—Pruritus—Epirubicin—hematologic cancer	4.22e-05	0.00016	CcSEcCtD
Halofantrine—Dizziness—Methotrexate—hematologic cancer	4.21e-05	0.00016	CcSEcCtD
Halofantrine—Diarrhoea—Epirubicin—hematologic cancer	4.08e-05	0.000155	CcSEcCtD
Halofantrine—Vomiting—Methotrexate—hematologic cancer	4.05e-05	0.000154	CcSEcCtD
Halofantrine—Rash—Methotrexate—hematologic cancer	4.01e-05	0.000152	CcSEcCtD
Halofantrine—Dermatitis—Methotrexate—hematologic cancer	4.01e-05	0.000152	CcSEcCtD
Halofantrine—Headache—Methotrexate—hematologic cancer	3.99e-05	0.000151	CcSEcCtD
Halofantrine—Asthenia—Doxorubicin—hematologic cancer	3.96e-05	0.00015	CcSEcCtD
Halofantrine—Dizziness—Epirubicin—hematologic cancer	3.94e-05	0.00015	CcSEcCtD
Halofantrine—Pruritus—Doxorubicin—hematologic cancer	3.9e-05	0.000148	CcSEcCtD
Halofantrine—Vomiting—Epirubicin—hematologic cancer	3.79e-05	0.000144	CcSEcCtD
Halofantrine—Nausea—Methotrexate—hematologic cancer	3.78e-05	0.000144	CcSEcCtD
Halofantrine—Diarrhoea—Doxorubicin—hematologic cancer	3.77e-05	0.000143	CcSEcCtD
Halofantrine—Rash—Epirubicin—hematologic cancer	3.76e-05	0.000143	CcSEcCtD
Halofantrine—Dermatitis—Epirubicin—hematologic cancer	3.75e-05	0.000143	CcSEcCtD
Halofantrine—Headache—Epirubicin—hematologic cancer	3.73e-05	0.000142	CcSEcCtD
Halofantrine—Dizziness—Doxorubicin—hematologic cancer	3.65e-05	0.000138	CcSEcCtD
Halofantrine—Nausea—Epirubicin—hematologic cancer	3.54e-05	0.000134	CcSEcCtD
Halofantrine—Vomiting—Doxorubicin—hematologic cancer	3.51e-05	0.000133	CcSEcCtD
Halofantrine—Rash—Doxorubicin—hematologic cancer	3.48e-05	0.000132	CcSEcCtD
Halofantrine—Dermatitis—Doxorubicin—hematologic cancer	3.47e-05	0.000132	CcSEcCtD
Halofantrine—Headache—Doxorubicin—hematologic cancer	3.45e-05	0.000131	CcSEcCtD
Halofantrine—Nausea—Doxorubicin—hematologic cancer	3.27e-05	0.000124	CcSEcCtD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	2.74e-05	0.000723	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—GSTM1—hematologic cancer	2.73e-05	0.000719	CbGpPWpGaD
Halofantrine—CYP2D6—Metapathway biotransformation—GSTM1—hematologic cancer	2.69e-05	0.000709	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	2.61e-05	0.000689	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	2.58e-05	0.000681	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—DCK—hematologic cancer	2.56e-05	0.000674	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—B3GAT1—hematologic cancer	2.56e-05	0.000674	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ASNS—hematologic cancer	2.56e-05	0.000674	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—SMPD3—hematologic cancer	2.54e-05	0.000668	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	2.53e-05	0.000666	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—HDC—hematologic cancer	2.43e-05	0.000639	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	2.36e-05	0.000623	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	2.3e-05	0.000607	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PHYH—hematologic cancer	2.28e-05	0.000599	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GMPS—hematologic cancer	2.28e-05	0.000599	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—FTCD—hematologic cancer	2.28e-05	0.000599	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CDA—hematologic cancer	2.22e-05	0.000584	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—B3GAT1—hematologic cancer	2.22e-05	0.000584	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ASNS—hematologic cancer	2.22e-05	0.000584	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—DCK—hematologic cancer	2.22e-05	0.000584	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.17e-05	0.000571	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PC—hematologic cancer	2.14e-05	0.000562	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HDC—hematologic cancer	2.1e-05	0.000553	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SMPD3—hematologic cancer	2.08e-05	0.000548	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—SLC35B2—hematologic cancer	2.06e-05	0.000543	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GBA—hematologic cancer	2.06e-05	0.000543	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.96e-05	0.000516	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.94e-05	0.000511	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CDA—hematologic cancer	1.92e-05	0.000506	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.91e-05	0.000504	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—MTAP—hematologic cancer	1.89e-05	0.000497	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—HRAS—hematologic cancer	1.85e-05	0.000488	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PC—hematologic cancer	1.85e-05	0.000487	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ASNS—hematologic cancer	1.82e-05	0.000479	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—B3GAT1—hematologic cancer	1.82e-05	0.000479	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—DCK—hematologic cancer	1.82e-05	0.000479	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GBA—hematologic cancer	1.79e-05	0.000471	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—SLC35B2—hematologic cancer	1.79e-05	0.000471	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.78e-05	0.00047	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.76e-05	0.000464	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HDC—hematologic cancer	1.72e-05	0.000454	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—FHL2—hematologic cancer	1.68e-05	0.000443	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—AGRN—hematologic cancer	1.65e-05	0.000434	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—MTAP—hematologic cancer	1.63e-05	0.00043	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CDA—hematologic cancer	1.58e-05	0.000416	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—IDH2—hematologic cancer	1.56e-05	0.000412	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—HMMR—hematologic cancer	1.56e-05	0.000412	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PC—hematologic cancer	1.52e-05	0.0004	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GMPS—hematologic cancer	1.49e-05	0.000392	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—FTCD—hematologic cancer	1.49e-05	0.000392	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PHYH—hematologic cancer	1.49e-05	0.000392	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ARNTL—hematologic cancer	1.47e-05	0.000387	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SLC35B2—hematologic cancer	1.47e-05	0.000386	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GBA—hematologic cancer	1.47e-05	0.000386	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—FHL2—hematologic cancer	1.46e-05	0.000384	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ACP5—hematologic cancer	1.43e-05	0.000377	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CA9—hematologic cancer	1.43e-05	0.000377	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—AGRN—hematologic cancer	1.43e-05	0.000376	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NCOR2—hematologic cancer	1.41e-05	0.000372	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.36e-05	0.000358	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HMMR—hematologic cancer	1.35e-05	0.000357	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—IDH2—hematologic cancer	1.35e-05	0.000357	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—IDH1—hematologic cancer	1.34e-05	0.000354	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—MTAP—hematologic cancer	1.34e-05	0.000353	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ABCC3—hematologic cancer	1.33e-05	0.00035	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTO1—hematologic cancer	1.33e-05	0.00035	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—TXN—hematologic cancer	1.33e-05	0.00035	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—SPHK1—hematologic cancer	1.3e-05	0.000343	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.28e-05	0.000336	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ARNTL—hematologic cancer	1.27e-05	0.000335	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—UGT1A1—hematologic cancer	1.25e-05	0.000329	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ACP5—hematologic cancer	1.24e-05	0.000326	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CA9—hematologic cancer	1.24e-05	0.000326	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NCOR2—hematologic cancer	1.22e-05	0.000322	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—SLC22A1—hematologic cancer	1.22e-05	0.00032	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CRABP1—hematologic cancer	1.22e-05	0.00032	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—FHL2—hematologic cancer	1.2e-05	0.000315	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.19e-05	0.000313	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—DCK—hematologic cancer	1.19e-05	0.000313	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ASNS—hematologic cancer	1.19e-05	0.000313	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ALOX5—hematologic cancer	1.18e-05	0.000312	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—AGRN—hematologic cancer	1.17e-05	0.000309	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—IDH1—hematologic cancer	1.16e-05	0.000307	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTO1—hematologic cancer	1.15e-05	0.000303	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—TXN—hematologic cancer	1.15e-05	0.000303	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ABCC3—hematologic cancer	1.15e-05	0.000303	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NUP98—hematologic cancer	1.15e-05	0.000302	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HDC—hematologic cancer	1.13e-05	0.000297	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—SPHK1—hematologic cancer	1.13e-05	0.000297	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ADCY7—hematologic cancer	1.11e-05	0.000293	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NCOA3—hematologic cancer	1.11e-05	0.000293	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—IDH2—hematologic cancer	1.11e-05	0.000293	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HMMR—hematologic cancer	1.11e-05	0.000293	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NUP214—hematologic cancer	1.11e-05	0.000291	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ABCG2—hematologic cancer	1.08e-05	0.000285	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—MTR—hematologic cancer	1.08e-05	0.000285	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—UGT1A1—hematologic cancer	1.08e-05	0.000285	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ENO2—hematologic cancer	1.06e-05	0.00028	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CRABP1—hematologic cancer	1.05e-05	0.000277	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—SLC22A1—hematologic cancer	1.05e-05	0.000277	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ARNTL—hematologic cancer	1.04e-05	0.000275	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CDA—hematologic cancer	1.03e-05	0.000272	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTT1—hematologic cancer	1.03e-05	0.000271	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ALOX5—hematologic cancer	1.03e-05	0.00027	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CA9—hematologic cancer	1.02e-05	0.000268	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ACP5—hematologic cancer	1.02e-05	0.000268	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—SDC1—hematologic cancer	1.01e-05	0.000265	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NCOR2—hematologic cancer	1e-05	0.000264	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NUP98—hematologic cancer	9.94e-06	0.000262	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PC—hematologic cancer	9.93e-06	0.000262	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ADCY7—hematologic cancer	9.65e-06	0.000254	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NCOA3—hematologic cancer	9.65e-06	0.000254	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	9.59e-06	0.000253	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GBA—hematologic cancer	9.59e-06	0.000253	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NUP214—hematologic cancer	9.58e-06	0.000252	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—IDH1—hematologic cancer	9.56e-06	0.000252	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	9.48e-06	0.00025	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ABCC3—hematologic cancer	9.45e-06	0.000249	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—TXN—hematologic cancer	9.45e-06	0.000249	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTO1—hematologic cancer	9.45e-06	0.000249	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ABCG2—hematologic cancer	9.38e-06	0.000247	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—MTR—hematologic cancer	9.38e-06	0.000247	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SPHK1—hematologic cancer	9.25e-06	0.000244	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ENO2—hematologic cancer	9.2e-06	0.000242	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTT1—hematologic cancer	8.93e-06	0.000235	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	8.88e-06	0.000234	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.79e-06	0.000231	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—MTAP—hematologic cancer	8.77e-06	0.000231	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—SDC1—hematologic cancer	8.72e-06	0.00023	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	8.64e-06	0.000228	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CRABP1—hematologic cancer	8.64e-06	0.000228	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CD44—hematologic cancer	8.56e-06	0.000226	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NQO1—hematologic cancer	8.56e-06	0.000226	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ALOX5—hematologic cancer	8.42e-06	0.000222	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	8.33e-06	0.000219	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	8.23e-06	0.000217	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NUP98—hematologic cancer	8.16e-06	0.000215	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYCS—hematologic cancer	8.1e-06	0.000213	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	8.05e-06	0.000212	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ADCY7—hematologic cancer	7.92e-06	0.000209	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NCOA3—hematologic cancer	7.92e-06	0.000209	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.87e-06	0.000207	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NUP214—hematologic cancer	7.86e-06	0.000207	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—FHL2—hematologic cancer	7.82e-06	0.000206	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—MTR—hematologic cancer	7.7e-06	0.000203	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ABCG2—hematologic cancer	7.7e-06	0.000203	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—AGRN—hematologic cancer	7.66e-06	0.000202	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ENO2—hematologic cancer	7.55e-06	0.000199	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CD44—hematologic cancer	7.42e-06	0.000195	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NQO1—hematologic cancer	7.42e-06	0.000195	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTT1—hematologic cancer	7.33e-06	0.000193	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HMMR—hematologic cancer	7.27e-06	0.000191	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—IDH2—hematologic cancer	7.27e-06	0.000191	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.26e-06	0.000191	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SDC1—hematologic cancer	7.16e-06	0.000189	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTP1—hematologic cancer	7.14e-06	0.000188	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYCS—hematologic cancer	7.02e-06	0.000185	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	6.97e-06	0.000184	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ARNTL—hematologic cancer	6.83e-06	0.00018	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ABCB1—hematologic cancer	6.76e-06	0.000178	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CA9—hematologic cancer	6.65e-06	0.000175	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ACP5—hematologic cancer	6.65e-06	0.000175	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTM1—hematologic cancer	6.56e-06	0.000173	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NCOR1—hematologic cancer	6.56e-06	0.000173	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NCOR2—hematologic cancer	6.56e-06	0.000173	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.28e-06	0.000165	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—IDH1—hematologic cancer	6.25e-06	0.000165	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTP1—hematologic cancer	6.19e-06	0.000163	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTO1—hematologic cancer	6.18e-06	0.000163	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ABCC3—hematologic cancer	6.18e-06	0.000163	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—TXN—hematologic cancer	6.18e-06	0.000163	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CD44—hematologic cancer	6.09e-06	0.00016	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NQO1—hematologic cancer	6.09e-06	0.00016	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SPHK1—hematologic cancer	6.05e-06	0.000159	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.99e-06	0.000158	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ABCB1—hematologic cancer	5.86e-06	0.000154	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5.81e-06	0.000153	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—MTHFR—hematologic cancer	5.8e-06	0.000153	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYCS—hematologic cancer	5.76e-06	0.000152	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	5.73e-06	0.000151	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NCOR1—hematologic cancer	5.68e-06	0.00015	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTM1—hematologic cancer	5.68e-06	0.00015	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	5.65e-06	0.000149	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CRABP1—hematologic cancer	5.65e-06	0.000149	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ALOX5—hematologic cancer	5.51e-06	0.000145	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NUP98—hematologic cancer	5.33e-06	0.00014	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ADCY7—hematologic cancer	5.18e-06	0.000136	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NCOA3—hematologic cancer	5.18e-06	0.000136	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NUP214—hematologic cancer	5.14e-06	0.000135	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTP1—hematologic cancer	5.08e-06	0.000134	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—MTR—hematologic cancer	5.04e-06	0.000133	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ABCG2—hematologic cancer	5.04e-06	0.000133	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—MTHFR—hematologic cancer	5.02e-06	0.000132	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ENO2—hematologic cancer	4.94e-06	0.00013	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PIK3CG—hematologic cancer	4.87e-06	0.000128	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ABCB1—hematologic cancer	4.81e-06	0.000127	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.79e-06	0.000126	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SDC1—hematologic cancer	4.68e-06	0.000123	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NCOR1—hematologic cancer	4.67e-06	0.000123	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTM1—hematologic cancer	4.67e-06	0.000123	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CREBBP—hematologic cancer	4.52e-06	0.000119	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.43e-06	0.000117	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PIK3CD—hematologic cancer	4.28e-06	0.000113	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ALB—hematologic cancer	4.23e-06	0.000111	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PIK3CG—hematologic cancer	4.22e-06	0.000111	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—MTHFR—hematologic cancer	4.12e-06	0.000109	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PIK3R1—hematologic cancer	4.05e-06	0.000107	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CD44—hematologic cancer	3.98e-06	0.000105	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NQO1—hematologic cancer	3.98e-06	0.000105	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CREBBP—hematologic cancer	3.91e-06	0.000103	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYCS—hematologic cancer	3.77e-06	9.92e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.74e-06	9.86e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PIK3CB—hematologic cancer	3.73e-06	9.84e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PIK3CD—hematologic cancer	3.71e-06	9.78e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ALB—hematologic cancer	3.66e-06	9.65e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	3.5e-06	9.23e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.47e-06	9.13e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.32e-06	8.75e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	3.23e-06	8.52e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PTEN—hematologic cancer	3.23e-06	8.5e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CREBBP—hematologic cancer	3.21e-06	8.46e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.14e-06	8.28e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—EP300—hematologic cancer	3.08e-06	8.11e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.05e-06	8.04e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.05e-06	8.04e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	3.05e-06	8.03e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ALB—hematologic cancer	3.01e-06	7.92e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.88e-06	7.58e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PTEN—hematologic cancer	2.8e-06	7.36e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.7e-06	7.1e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—EP300—hematologic cancer	2.67e-06	7.02e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.66e-06	7e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PTEN—hematologic cancer	2.29e-06	6.04e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PIK3CA—hematologic cancer	2.28e-06	6e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.27e-06	5.97e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—EP300—hematologic cancer	2.19e-06	5.76e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.1e-06	5.53e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.99e-06	5.25e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.97e-06	5.19e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ALB—hematologic cancer	1.97e-06	5.18e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.88e-06	4.95e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—AKT1—hematologic cancer	1.86e-06	4.9e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.74e-06	4.57e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.62e-06	4.26e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—AKT1—hematologic cancer	1.61e-06	4.24e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.5e-06	3.95e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—EP300—hematologic cancer	1.43e-06	3.77e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—AKT1—hematologic cancer	1.32e-06	3.48e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.06e-06	2.79e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—AKT1—hematologic cancer	8.65e-07	2.28e-05	CbGpPWpGaD
